Cargando…

Family history and risk of ductal carcinoma in situ and triple negative breast cancer in a Han Chinese population: a case–control study

BACKGROUND: The association between family history and risk of triple negative breast cancer and ductal carcinoma in situ (DCIS) has not been well investigated, especially in Asian populations. We investigated the association between family history and risk of DCIS or triple negative breast cancer i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Wenbin, Pan, Hong, Liang, Mengdi, Xia, Kai, Liang, Xiuqing, Xue, Jinqiu, Cheng, Lin, Xue, Jialei, Chen, Si, Liu, Xiaoan, Ding, Qiang, Ling, Lijun, Wang, Shui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3850692/ https://www.ncbi.nlm.nih.gov/pubmed/24083544 http://dx.doi.org/10.1186/1477-7819-11-248

Ejemplares similares

Low Serum Creatine Kinase Levels in Breast Cancer Patients: A Case-Control Study
por: Pan, Hong, et al.
Publicado: (2013)

Risk of breast cancer and family history of other cancers in first-degree relatives in Chinese women: a case control study
por: Zhou, Wenbin, et al.
Publicado: (2014)

Clinicopathological characteristics and prognosis of triple-negative breast cancer invasive ductal carcinoma with ductal carcinoma in situ
por: Liu, Yang, et al.
Publicado: (2023)

Comparison of Ablation Zones among Different Tissues Using 2450-MHz Cooled-Shaft Microwave Antenna: Results in Ex Vivo Porcine Models
por: Zhou, Wenbin, et al.
Publicado: (2013)

Molecular Subtype Classification Is a Determinant of Non-Sentinel Lymph Node Metastasis in Breast Cancer Patients with Positive Sentinel Lymph Nodes
por: Zhou, Wenbin, et al.
Publicado: (2012)

The Risk of Amenorrhea Is Related to Chemotherapy-Induced Leucopenia in Breast Cancer Patients Receiving Epirubicin and Taxane Based Chemotherapy
por: Zhou, Wenbin, et al.
Publicado: (2012)

DNA methylation landscape of triple-negative ductal carcinoma in situ (DCIS) progressing to the invasive stage in canine breast cancer
por: Beetch, Megan, et al.
Publicado: (2020)

Up-regulation of S100A16 expression promotes epithelial-mesenchymal transition via Notch1 pathway in breast cancer
por: Zhou, Wenbin, et al.
Publicado: (2014)

MiR-25-3p promotes the proliferation of triple negative breast cancer by targeting BTG2
por: Chen, Hua, et al.
Publicado: (2018)

Modeling the natural history of ductal carcinoma in situ based on population data
por: Chootipongchaivat, Sarocha, et al.
Publicado: (2020)

Author Correction: DNA methylation landscape of triple-negative ductal carcinoma in situ (DCIS) progressing to the invasive stage in canine breast cancer
por: Beetch, Megan, et al.
Publicado: (2020)

Aldehyde dehydrogenase 1 expression correlates with the invasion of breast cancer
por: Pan, Hong, et al.
Publicado: (2015)

A clinical radiomics nomogram preoperatively to predict ductal carcinoma in situ with microinvasion in women with biopsy-confirmed ductal carcinoma in situ: a preliminary study
por: Huang, Zhou, et al.
Publicado: (2023)

The natural history of ductal carcinoma in situ (DCIS) in simulation models: A systematic review
por: Poelhekken, Keris, et al.
Publicado: (2023)

A Novel Finding of Sentinel Lymphatic Channels in Early Stage Breast Cancer Patients: Which May Influence Detection Rate and False-Negative Rate of Sentinel Lymph Node Biopsy
por: Wang, Minghai, et al.
Publicado: (2012)

Ductal carcinoma in situ (DCIS)
por: Holland, R
Publicado: (2002)

Ductal Carcinoma In Situ of the Breast
por: Lee, Richard J., et al.
Publicado: (2012)

Breast Ductal Carcinoma In Situ
por: Sacchini, Virgilio, et al.
Publicado: (2012)

There Is No Association between MicroRNA Gene Polymorphisms and Risk of Triple Negative Breast Cancer in a Chinese Han Population
por: Ma, Fei, et al.
Publicado: (2013)

Significance of boost radiotherapy in early invasive ductal breast cancer with ductal carcinoma in situ component under negative surgical margins
por: Shimizu, Naoko, et al.
Publicado: (2021)

Expression and clinical significance of MAPK and EGFR in triple-negative breast cancer
por: Jiang, Weihua, et al.
Publicado: (2020)

Different distribution of breast ductal carcinoma in situ, ductal carcinoma in situ with microinvasion, and invasion breast cancer
por: Wei, Zhang, et al.
Publicado: (2012)

Multiple Microinvasion Foci in Ductal Carcinoma In Situ Is Associated With an Increased Risk of Recurrence and Worse Survival Outcome
por: Si, Jing, et al.
Publicado: (2020)

Comparison of Clinicopathological Features and Prognosis in Triple-Negative and Non-Triple Negative Breast Cancer
por: Qiu, Jingdan, et al.
Publicado: (2016)

Concurrent Gene Signatures for Han Chinese Breast Cancers
por: Huang, Chi-Cheng, et al.
Publicado: (2013)

Sharp Downregulation of Hub Genes Associated With the Pathogenesis of Breast Cancer From Ductal Carcinoma In Situ to Invasive Ductal Carcinoma
por: Wang, Yao, et al.
Publicado: (2021)

Imaging of Noncalcified Ductal Carcinoma In Situ
por: Bragg, Ashley, et al.
Publicado: (2021)

Genomic differences between pure ductal carcinoma in situ and synchronous ductal carcinoma in situ with invasive breast cancer
por: Kim, Shinn Young, et al.
Publicado: (2015)

Comparison of breast ductal carcinoma in situ and ductal carcinoma in situ with microinvasion, and analysis of axillary lymph node metastasis
por: Zhang, Geng, et al.
Publicado: (2020)

The Application of Whole-Process Case Management in Patients with Triple-Negative Breast Cancer
por: Zhao, Yunyan, et al.
Publicado: (2022)

Triple negativity and young age as prognostic factors in lymph node-negative invasive ductal carcinoma of 1 cm or less
por: Kwon, Ji Hyun, et al.
Publicado: (2010)

Evaluation of ductal carcinoma in situ grade via triple-modal molecular imaging of B7-H3 expression
por: Bachawal, Sunitha, et al.
Publicado: (2020)

The predictive value of calcification for the grading of ductal carcinoma in situ in Chinese patients
por: Kong, Jianchun, et al.
Publicado: (2020)

Comparison of the ductal carcinoma in situ between White Americans and Chinese Americans
por: Kuang, Xin-Wen, et al.
Publicado: (2021)

Magnetic Resonance Imaging after Completion of Neoadjuvant Chemotherapy Can Accurately Discriminate between No Residual Carcinoma and Residual Ductal Carcinoma In Situ in Patients with Triple-Negative Breast Cancer
por: Park, Seho, et al.
Publicado: (2016)

Unraveling the Pivotal Network of Ultrasound and Somatic Mutations in Triple-Negative and Non-Triple-Negative Breast Cancer
por: Huang, Yunxia, et al.
Publicado: (2023)

Association of p53 expression with poor prognosis in patients with triple-negative breast invasive ductal carcinoma
por: Li, Jing-ping, et al.
Publicado: (2019)

CUEDC2 Drives β-Catenin Nuclear Translocation and Promotes Triple-Negative Breast Cancer Tumorigenesis
por: Han, Shuyan, et al.
Publicado: (2022)

Immunohistochemical categorisation of ductal carcinoma in situ of the breast
por: Meijnen, P, et al.
Publicado: (2008)

Magnetic resonance imaging of ductal carcinoma in situ
por: Kuhl, C
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_vjmnfllq6e8bq7bfbtajd9keno